Accenture (ACN) appoints Julie Sweet as CEO of its board of directors
[ad_1]
Accenture plc ACN yesterday announced the appointment of CEO Julie Sweet as additional chairman of the board, replacing David Rowland. The change will be effective from September 1, 2021.
Rowland, who has been the company’s executive chairman since September 2019 and interim CEO from January 2019 to September 2019, will retire on the same date. Prior to becoming Interim CEO, he served as Chief Financial Officer of Accenture for six years, which was preceded by his service as Senior Vice President of Finance, also for a period of six years.
Sweet succeeded Rowland as CEO and also joined the Board of Directors in September 2019. She has been instrumental in setting the growth model for the company and in strengthening sustainability and l ‘equality.
“Julie’s appointment to the additional position of Chairman of the Board of Directors reflects her exceptional career as a senior executive for more than a decade,†said Gilles Pélisson, Lead Independent Director of the Board of Directors of Accenture.
Notably, Accenture shares have gained 34.2% in the last year, outperforming the 34.1% growth of the Zacks S&P 500 composite but underperforming the rally by 35.9% of the industry to which it belongs. .
Accenture PLC Award
Accenture PLC Award | Accenture PLC quote
Zacks rank and actions to consider
Accenture currently holds a Zacks Rank # 3 (Hold).
Investors interested in Zacks’ broader business services industry may also consider stocks such as Equifax EFX, Cross Country Health Care CCRN and Charles River Partners CRAI, each wearing a Zacks Rank # 2 (Buy). You can see The full list of today’s Zacks # 1 (strong buy) stocks here.
The expected long-term growth rate of earnings per share (three to five years) for Equifax, Cross Country Healthcare and Charles River is set at 14%, 10.5% and 15.5%, respectively.
5 actions in the process of doubling
Each has been selected by a Zacks expert as the # 1 favorite stock to earn + 100% or more in 2020. Each comes from a different industry and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stock in this report is flying under Wall Street’s radar, which provides a great opportunity to get into the ground floor.
Today, discover these 5 potential circuits >>
Click to get this free report
Equifax, Inc. (EFX): Free Stock Analysis Report
Charles River Associates (CRAI): Free Stock Analysis Report
Accenture PLC (ACN): Free Stock Analysis Report
Cross Country Healthcare, Inc. (CCRN): Free Inventory Analysis Report
To read this article on Zacks.com, click here.
Zacks investment research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
[ad_2]